INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes
- 1 February 1996
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 37 (1) , 65-76
- https://doi.org/10.1007/bf01806633
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Comparative efficiency of a survival‐based case‐control design and a random selection cohort designStatistics in Medicine, 1991
- A novel cyclin encoded by a bcl1-linked candidate oncogeneNature, 1991
- HER-2 oncogene amplification and overall survival of breast carcinoma patientsEuropean Journal of Cancer and Clinical Oncology, 1990
- Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogeneCell, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Molecular cloning and sequencing of the Mtv-1 LTR: Evidence for a LTR sequence alterationVirus Research, 1989
- Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogeneCell, 1988
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986